메뉴 건너뛰기




Volumn 92, Issue 5, 2002, Pages 715-721

The anthrax vaccine program: An analysis of the CDC's recommendations for vaccine use

(1)  Nass, Meryl a  

a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE;

EID: 0036235589     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.92.5.715     Document Type: Review
Times cited : (22)

References (65)
  • 3
    • 0001257846 scopus 로고
    • Biological products: Bacterial vaccines and toxoids: Implementation of efficacy review. Proposed rule
    • (1985) 50 Federal Register 51058
  • 7
    • 85037013373 scopus 로고    scopus 로고
    • (responsible head of Michigan Biological Products Institute) October 5, 1995. Provided to the House Subcommittee on National Security. Washington, DC: House Committee on Government Reform Anthrax Vaccine Archive
    • (1999) Letter with enclosure to R. Myers
    • Winegar, A.J.1
  • 8
    • 85037011208 scopus 로고    scopus 로고
    • Information paper. Gilbreath MJ (medical project manager, Joint Program Office for Biological Defense). November 10, 1995. Provided to the House Subcommittee on National Security, 1999. Washington, DC: House Committee on Government Reform Anthrax Vaccine Archive
  • 9
    • 0033125997 scopus 로고    scopus 로고
    • The learned intermediary doctrine and patient package inserts: A balanced approach to preventing drug-related injury
    • (1999) Stanford Law Rev , vol.51 , pp. 1343-1371
    • Paytash, C.1
  • 17
    • 85037011714 scopus 로고    scopus 로고
    • 21 CFR 10.85 (1979)
  • 19
    • 85037025230 scopus 로고    scopus 로고
    • Dept of Defense press briefing, December 15 1997
    • (1997)
  • 25
    • 0034724524 scopus 로고    scopus 로고
    • Surveillance for adverse events associated with anthrax vaccination - US Department of Defense, 1998-2000
    • (2000) MMWR Morb Mortal Wkly Rep , vol.49 , pp. 341-345
  • 27
    • 0034672416 scopus 로고    scopus 로고
    • Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices
    • (2000) MMWR Morb Mortal Wly Rep , vol.49 , pp. 1-20
  • 28
    • 85037006852 scopus 로고    scopus 로고
    • Anthrax vaccine is safe, US health experts say
    • July 10; Health
    • (2000) Reuters
    • Bussey, E.1
  • 29
    • 85037014313 scopus 로고    scopus 로고
    • (director, Michigan Biologics Products Institute). April 28. Washington, DC: House Committee on Government Reform Anthrax Vaccine Archive
    • (1998) Letter to R. Myers
    • Zoon, K.1
  • 32
    • 85037007457 scopus 로고    scopus 로고
    • Bioport corporation forms strategic alliance with Hollister-Stier laboratories
    • May 29
    • (2001) PR News
  • 33
    • 85037019908 scopus 로고    scopus 로고
    • (CEO, Bio-Port Corporation). September 23. Washington, DC: House Committee on Government Reform Anthrax Vaccine Archive
    • (1998) Letter to EI-Hibn F
    • Little, J.S.1
  • 38
    • 85037014645 scopus 로고    scopus 로고
    • (director, James Madison Project). December 10. Washington, DC: House Committee on Government Reform Anthrax Vaccine Archive
    • (1999) Letter to Zaid M
    • Blanck, R.R.1
  • 45
    • 0031012532 scopus 로고    scopus 로고
    • Self-reported illness and health among Gulf War veterans
    • (1997) JAMA , vol.277 , pp. 238-245
  • 46
    • 0034669707 scopus 로고    scopus 로고
    • Prevalence and patterns of Gulf War illness in Kansas veterans: Association of symptoms with characteristics of person, place, and time of military service
    • (2000) Am J Epidemiol , vol.152 , pp. 992-1002
    • Steele, L.1
  • 50
    • 0034690737 scopus 로고    scopus 로고
    • Role of vaccinations as risk factors for ill health in veterans of the Gulf War: Cross sectional study
    • (2000) BMJ , vol.320 , pp. 1363-1367
    • Hotoph, M.1    David, A.2    Hull, L.3
  • 51
    • 0034706313 scopus 로고    scopus 로고
    • Reanalysis of Gulf War vaccination data does not contradict findings
    • (2000) BMJ , vol.321 , pp. 761-762
    • Hotoph, M.1
  • 56
    • 85037009951 scopus 로고    scopus 로고
    • Department of Defense. Press Release No. 262-01. June 11
    • (2001)
  • 58
    • 85037008012 scopus 로고    scopus 로고
    • Feres v United States, 340 US 135 (1950)
  • 62
    • 0032819614 scopus 로고    scopus 로고
    • Vaccines, pharmaceutical products, and bioterrorism: Challenges for the US Food and Drug Administration
    • (1999) Emerging Infect Dis , vol.5 , pp. 534-536
    • Zoon, K.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.